Intramuscular SARS-CoV-2 vaccines elicit varying degrees of plasma and salivary antibody responses as compared to natural infection | 30/08/2021 | |
SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature | 30/08/2021 | |
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study | 28/08/2021 | |
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study | 27/08/2021 | |
Airborne transmission of respiratory viruses | 27/08/2021 | |
Factors Associated With Household Transmission of SARS-CoV-2 | 27/08/2021 | |
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | 25/08/2021 | |
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections | 25/08/2021 | |
The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines | 23/08/2021 | |
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children | 23/08/2021 | |
Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker | 20/08/2021 | |
A glycan gate controls opening of the SARS-CoV-2 spike protein | 19/08/2021 | |
A molecular test based on RT-LAMP for rapid, sensitive and inexpensive colorimetric detection of SARS-CoV-2 in clinical samples | 12/08/2021 | |
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study | 11/08/2021 | |
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial | 10/08/2021 | |
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis | 09/08/2021 | |
Receipt of mRNA COVID-19 vaccines preconception and during pregnancy and risk of self-reported spontaneous abortions, CDC v-safe COVID-19 Vaccine Pregnancy Registry 2020-21 | 09/08/2021 | |
Receipt of mRNA COVID-19 vaccines preconception and during pregnancy and risk of self-reported spontaneous abortions, CDC v-safe COVID-19 Vaccine Pregnancy Registry 2020-21 | 09/08/2021 | |
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence | 08/08/2021 | |
COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study | 05/08/2021 | |
Antimicrobial Consumption among 66 Acute Care Hospitals in Catalonia: Impact of the COVID-19 Pandemic | 04/08/2021 | |
Physiologic Response to the Pfizer-BioNTech COVID-19 Vaccine Measured Using Wearable Devices: Prospective Observational Study | 04/08/2021 | |
Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients | 03/08/2021 | |
Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity | 03/08/2021 | |
Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2 | 03/08/2021 | |
Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids | 02/08/2021 | |
COVID-19 vaccine response in people with multiple sclerosis | 01/08/2021 | |
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants | 31/07/2021 | |
Post-viral effects of COVID-19 in the olfactory system and their implications | 30/07/2021 | |
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia | 29/07/2021 | |
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | 28/07/2021 | |
Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine | 28/07/2021 | |
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection | 27/07/2021 | |
Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis | 27/07/2021 | |
Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals | 26/07/2021 | |
Long covid - mechanisms, risk factors, and management | 26/07/2021 | |
Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID | 26/07/2021 | |
SARS-CoV-2 Initiates Programmed Cell Death in Platelets | 23/07/2021 | |
Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study | 22/07/2021 | |
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases | 22/07/2021 | |
Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma | 22/07/2021 | |
Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein | 22/07/2021 | |
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | 20/07/2021 | |
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19) | 18/07/2021 | |
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection | 16/07/2021 | |
Estimating epidemiologic dynamics from cross-sectional viral load distributions | 16/07/2021 | |
Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis | 15/07/2021 | |
Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8+ T cells | 15/07/2021 | |
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 | 15/07/2021 | |
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape | 14/07/2021 | |
Daily sampling of early SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness | 13/07/2021 | |
Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study | 13/07/2021 | |
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey | 08/07/2021 | |
Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls | 08/07/2021 | |
Viral infection and transmission in a large well-traced outbreak caused by the Delta SARS-CoV-2 variant | 07/07/2021 | |
Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study | 06/07/2021 | |
Lack of consideration of sex and gender in COVID-19 clinical studies | 06/07/2021 | |
Science, not speculation, is essential to determine how SARS-CoV-2 reached humans | 05/07/2021 | |
Unpredictable, Counter-Intuitive Geoclimatic and Demographic Correlations of COVID-19 Spread Rates | 05/07/2021 | |
Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS | 04/07/2021 | |
Nueva alternativa para el tratamiento para Covid 19 en Ecuador | 01/07/2021 | |
A synthetic defective interfering SARS-CoV-2 | 01/07/2021 | |
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans | 01/07/2021 | |
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern | 01/07/2021 | |
SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study | 30/06/2021 | |
Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study | 30/06/2021 | |
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses | 28/06/2021 | |
Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection | 28/06/2021 | |
Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19 | 28/06/2021 | |
Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study | 25/06/2021 | |
The Safety of COVID-19 Vaccinations - We Should Rethink the Policy | 24/06/2021 | |
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies | 23/06/2021 | |
International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19 | 23/06/2021 | |
SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough | 22/06/2021 | |
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study | 22/06/2021 | |
Nosocomial Outbreak of COVID-19 in a Hematologic Ward | 22/06/2021 | |
Dysregulation of brain and choroid plexus cell types in severe COVID-19 | 21/06/2021 | |
Rapid spread of the SARS-CoV-2 variant in the area of Paris (France) in June 2021 | 20/06/2021 | |
SARS-CoV-2 vaccination in people with HIV | 18/06/2021 | |
Long COVID has exposed medicine's blind-spot | 18/06/2021 | |
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial | 18/06/2021 | |
Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individuals. | 18/06/2021 | |
Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection | 17/06/2021 | |
Vitamin D deficiency is associated with higher hospitalisation risk from COVID-19: a retrospective case-control study | 17/06/2021 | |
Molnupiravir, an Oral Antiviral Treatment for COVID-19 | 17/06/2021 | |
SARS-CoV-2 Infects Hamster Testes | 17/06/2021 | |
SARS-CoV-2 spike P681R mutation enhances and accelerates viral fusion | 16/06/2021 | |
Prevalence of Low Level of Vitamin D Among COVID-19 Patients and Associated Risk Factors in India - A Hospital-Based Study | 15/06/2021 | |
Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19 | 15/06/2021 | |
The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article | 15/06/2021 | |
Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients | 15/06/2021 | |
Role of meteorological factors in the transmission of SARS-CoV-2 in the United States | 14/06/2021 | |
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial | 12/06/2021 | |
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial | 11/06/2021 | |
Viral infiltration of pancreatic islets in patients with COVID-19 | 10/06/2021 | |
Analysis of cell-mediated immunity in people with long Covid | 09/06/2021 | |
Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization | 09/06/2021 | |
Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection | 09/06/2021 | |
Predicted Coronavirus Nsp5 Protease Cleavage Sites in the Human Proteome: A Resource for SARS-CoV-2 Research | 07/06/2021 | |
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 | 07/06/2021 | |
ROS/RNS balancing, aerobic fermentation regulation and cell cycle control a complex early trait ('CoV-MAC-TED') for combating SARS-CoV-2-induced cell reprogramming | 06/06/2021 | |
Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro | 05/06/2021 | |
Uncertain effects of the pandemic on respiratory viruses | 04/06/2021 | |
The total number and mass of SARS-CoV-2 virions | 03/06/2021 | |
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination | 03/06/2021 | |
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs | 01/06/2021 | |
The Beauty of Simplicity: Delayed-Type Hypersensitivity Reaction to Measure Cellular Immune Responses in RNA-SARS-Cov-2 Vaccinated Individuals | 01/06/2021 | |
COVID Eyes: REM in COVID-19 Survivors | 01/06/2021 | |
SARS-CoV-2 variants, spike mutations and immune escape | 01/06/2021 | |
Physical activity guidelines for older people: knowledge gaps and future directions | 01/06/2021 | |
Increased extravascular lung water index (EVLWI) reflects rapid non-cardiogenic oedema and mortality in COVID-19 associated ARDS | 01/06/2021 | |
Determinants of Catalan Public Primary Care Professionals' Intention to Use Digital Clinical Consultations (eConsulta) in the Post - COVID-19 Context: Mixed Methods Study | 01/06/2021 | |
Africa's need for more COVID-19 clinical trials | 29/05/2021 | |
The SARS-CoV-2 variants associated with infections in India, B.1.617, show enhanced spike cleavage by furin | 28/05/2021 | |
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC | 26/05/2021 | |
Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19 | 26/05/2021 | |
Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice | 25/05/2021 | |
Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients With COVID-19 | 25/05/2021 | |
Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19 | 25/05/2021 | |
SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors | 25/05/2021 | |
Complement control for COVID-19 | 25/05/2021 | |
Hyperpolarized 129Xe MRI Abnormalities in Dyspneic Participants 3 Months after COVID-19 Pneumonia: Preliminary Results | 25/05/2021 | |
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial | 25/05/2021 | |
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans | 24/05/2021 | |
Virological and serological characterization of critically ill patients with COVID-19 in the UK: Interactions of viral load, antibody status and B.1.1.7 variant infection | 24/05/2021 | |
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection | 24/05/2021 | |
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis | 23/05/2021 | |
Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra | 21/05/2021 | |
Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform | 21/05/2021 | |
A Case for Montelukast in COVID-19: "The use of Computational Docking to estimate the effects of Montelukast on potential viral main protease catalytic site" | 21/05/2021 | |
The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant | 20/05/2021 | |
Face masks effectively limit the probability of SARS-CoV-2 transmission | 20/05/2021 | |
Vitamin C Binds to SARS Coronavirus-2 Main Protease Essential for Viral Replication | 20/05/2021 | |
Neurotropic Effects of SARS-CoV-2 Modeled by the Human Brain Organoids | 20/05/2021 | |
SARS-CoV-2 infects human pancreatic b-cells and elicits b-cell impairment | 18/05/2021 | |
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19 | 18/05/2021 | |
Assessing the effect of beard hair lengths on face masks used as personal protective equipment during the COVID-19 pandemic | 18/05/2021 | |
Viral RNA in City Wastewater as a Key Indicator of COVID-19 Recrudescence and Containment Measures Effectiveness | 17/05/2021 | |
Why have so many African leaders died of COVID-19? | 17/05/2021 | |
Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries | 17/05/2021 | |
Disease surveillance for the COVID-19 era: time for bold change | 14/05/2021 | |
Investigate the origins of COVID-19 | 14/05/2021 | |
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit | 13/05/2021 | |
Encephalitis as Neurological Complication of COVID-19: A Systematic Review and Meta Analysis of Incidence, Outcomes and Predictors | 13/05/2021 | |
An artificial intelligence system for predicting the deterioration of COVID-19 patients in the emergency department | 12/05/2021 | |
Persistence of Antibody and Cellular Immune Responses in COVID-19 patients over Nine Months after Infection | 12/05/2021 | |
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort | 10/05/2021 | |
A global database of COVID-19 vaccinations | 10/05/2021 | |
Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home | 10/05/2021 | |
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness | 08/05/2021 | |
Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues | 06/05/2021 | |
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients | 05/05/2021 | |
Delayed production of neutralizing antibodies correlates with fatal COVID-19 | 05/05/2021 | |
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant | 05/05/2021 | |
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes | 04/05/2021 | |
Obstructive sleep apnea is highly prevalent in COVID19 moderate to severe ARDS survivors: Findings of level I Polysomnography in a tertiary care hospital | 01/05/2021 | |
Influenza vaccination during the coronavirus pandemic: intention to vaccinate among the at-risk population in the Central Catalonia Health Region (VAGCOVID) | 01/05/2021 | |
Complicaciones neurológicas por coronavirus y COVID-19 | 01/05/2021 | |
LY-CoV1404 potently neutralizes SARS-CoV-2 variants | 30/04/2021 | |
Anti-intellectualism and the mass public's response to the COVID-19 pandemic | 28/04/2021 | |
Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut | 27/04/2021 | |
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | 27/04/2021 | |
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study | 27/04/2021 | |
Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination | 27/04/2021 | |
New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19 | 26/04/2021 | |
Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel | 24/04/2021 | |
Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK's COVID-19 Infection Survey | 23/04/2021 | |
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study | 23/04/2021 | |
High-dimensional characterization of post-acute sequalae of COVID-19 | 22/04/2021 | |
A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin | 22/04/2021 | |
Rapid induction of antigen-specific CD4+ T cells guides coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination | 22/04/2021 | |
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients | 21/04/2021 | |
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons | 21/04/2021 | |
Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management | 20/04/2021 | |
Post-acute COVID-19 outcomes in children with mild and asymptomatic disease | 20/04/2021 | |
Effects of Regular Physical Activity on the Immune System, Vaccination and Risk of Community-Acquired Infectious Disease in the General Population: Systematic Review and Meta-Analysis | 20/04/2021 | |
In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients | 20/04/2021 | |
Neutralizing monoclonal antibodies for treatment of COVID-19 | 19/04/2021 | |
Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology | 19/04/2021 | |
Germline variants in UNC13D and AP3B1 are enriched in COVID-19 patients experiencing severe cytokine storms | 19/04/2021 | |
Fitted Filtration Efficiency of Double Masking During the COVID-19 Pandemic | 16/04/2021 | |
Indoor Air Changes and Potential Implications for SARS-CoV-2 Transmission | 16/04/2021 | |
Ten scientific reasons in support of airborne transmission of SARS-CoV-2 | 15/04/2021 | |
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients | 15/04/2021 | |
Generation of recombinant hyperimmune globulins from diverse B-cell repertoires | 15/04/2021 | |
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study | 15/04/2021 | |
A guideline to limit indoor airborne transmission of COVID-19 | 15/04/2021 | |
Covid-19 has redefined airborne transmission | 14/04/2021 | |
Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients | 13/04/2021 | |
Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses | 12/04/2021 | |
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study | 12/04/2021 | |
Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals following mRNA vaccination | 12/04/2021 | |
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) | 09/04/2021 | |
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | 09/04/2021 | |
Characteristics and Disease Severity of US Children and Adolescents Diagnosed With COVID-19 | 09/04/2021 | |
Helping the Public Understand Adverse Events Associated With COVID-19 Vaccinations | 09/04/2021 | |
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial | 09/04/2021 | |
SARS-CoV-2 mRNA vaccines induce a robust germinal centre reaction in humans | 09/04/2021 | |
Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern. | 09/04/2021 | |
Correlates of protection from SARS-CoV-2 infection | 09/04/2021 | |
| | |